These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33003069)
41. Exposure to di-n-octyl phthalate during puberty induces hypergonadotropic hypogonadism caused by Leydig cell hyperplasia but reduced steroidogenic function in male rats. Zhu X; Hu M; Ji H; Huang T; Ge RS; Wang Y Ecotoxicol Environ Saf; 2021 Jan; 208():111432. PubMed ID: 33075588 [TBL] [Abstract][Full Text] [Related]
42. Leydig cell density and function and their relation to gonadotropins in infertile oligospermic men with varicocele. Weiss DB; Rodrigues-Rigau L; Smith KD; Grotjan EH; Steinberger E Isr J Med Sci; 1979 Jul; 15(7):556-63. PubMed ID: 478817 [TBL] [Abstract][Full Text] [Related]
43. Dose-response effects of gonadotropin-releasing hormone on plasma concentrations of gonadotropins and testosterone in fertile and subfertile stallions. Roser JF; Hughes JP J Androl; 1992; 13(6):543-50. PubMed ID: 1293134 [TBL] [Abstract][Full Text] [Related]
44. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism. Grinspon RP; Rey RA Horm Res Paediatr; 2010; 73(2):81-92. PubMed ID: 20190544 [TBL] [Abstract][Full Text] [Related]
45. Differentiation of human adipose derived stem cells into Leydig-like cells with molecular compounds. Chen Y; Li C; Ji W; Wang L; Chen X; Zhao S; Xu Z; Ge R; Guo X J Cell Mol Med; 2019 Sep; 23(9):5956-5969. PubMed ID: 31293077 [TBL] [Abstract][Full Text] [Related]
46. Generation of Leydig-like cells: approaches, characterization, and challenges. Li ZH; Lu JD; Li SJ; Chen HL; Su ZJ Asian J Androl; 2022; 24(4):335-344. PubMed ID: 35017389 [TBL] [Abstract][Full Text] [Related]
47. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. Kaminetsky J; Werner M; Fontenot G; Wiehle RD J Sex Med; 2013 Jun; 10(6):1628-35. PubMed ID: 23530575 [TBL] [Abstract][Full Text] [Related]
48. Temperature and germ cell regulation of Leydig cell proliferation stimulated by Sertoli cell-secreted mitogenic factor: a possible role in cryptorchidism. Wu N; Murono EP Andrologia; 1996; 28(5):247-57. PubMed ID: 8893092 [TBL] [Abstract][Full Text] [Related]
49. New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men. Karakas SE; Surampudi P Adv Clin Chem; 2018; 86():71-125. PubMed ID: 30144842 [TBL] [Abstract][Full Text] [Related]
50. Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment. Helo S; Mahon J; Ellen J; Wiehle R; Fontenot G; Hsu K; Feustel P; Welliver C; McCullough A BJU Int; 2017 Jan; 119(1):171-176. PubMed ID: 27511863 [TBL] [Abstract][Full Text] [Related]
51. Luteinizing hormone signaling is involved in synchronization of Leydig cell's clock and is crucial for rhythm robustness of testosterone production†. Baburski AZ; Andric SA; Kostic TS Biol Reprod; 2019 May; 100(5):1406-1415. PubMed ID: 30722003 [TBL] [Abstract][Full Text] [Related]
52. Enhancement of long-term testosterone secretion and steroidogenic enzyme expression in human Leydig cells by co-culture with human Sertoli cell-enriched preparations. Lejeune H; Sanchez P; Saez JM Int J Androl; 1998 Jun; 21(3):129-40. PubMed ID: 9669197 [TBL] [Abstract][Full Text] [Related]
53. Varicocele Repair Versus Testosterone Therapy for Older Hypogonadal Men with Clinical Varicocele and Low Testosterone. Bernie HL; Goldstein M Eur Urol Focus; 2018 Apr; 4(3):314-316. PubMed ID: 30316825 [TBL] [Abstract][Full Text] [Related]
54. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism. Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099 [TBL] [Abstract][Full Text] [Related]
55. Unexpected effect of testosterone in hypergonadotropic hypogonadism and nodular Leydig cell hiperplasia. Report of one case. Devoto C E; Aravena C L Rev Med Chil; 2022 May; 150(5):682-687. PubMed ID: 37906770 [TBL] [Abstract][Full Text] [Related]
57. Alternatives to Testosterone Therapy: A Review. Lo EM; Rodriguez KM; Pastuszak AW; Khera M Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957 [TBL] [Abstract][Full Text] [Related]
58. Clomiphene Citrate for the Treatment of Hypogonadism. Wheeler KM; Sharma D; Kavoussi PK; Smith RP; Costabile R Sex Med Rev; 2019 Apr; 7(2):272-276. PubMed ID: 30522888 [TBL] [Abstract][Full Text] [Related]
59. Effects of luteinizing hormone, follicle-stimulating hormone, and epidermal growth factor on expression and kinase activity of cyclin-dependent kinase 5 in Leydig TM3 and Sertoli TM4 cell lines. Musa FR; Takenaka I; Konishi R; Tokuda M J Androl; 2000; 21(3):392-402. PubMed ID: 10819446 [TBL] [Abstract][Full Text] [Related]
60. Directing differentiation of human induced pluripotent stem cells toward androgen-producing Leydig cells rather than adrenal cells. Li L; Li Y; Sottas C; Culty M; Fan J; Hu Y; Cheung G; Chemes HE; Papadopoulos V Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23274-23283. PubMed ID: 31591190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]